MCL coexpression mm9:177

Phase1 CAGE Peaks

	Short description
Mm9::chr10:19654098..19654123,+	p3@Map3k5
Mm9::chr10:22022300..22022354,-	p1@uc007eph.1 p1@uc007epi.1
Mm9::chr11:45869667..45869677,+	p4@Adam19
Mm9::chr11:94071142..94071166,+	p@chr11:94071142..94071166 +
Mm9::chr12:102075624..102075643,-	p@chr12:102075624..102075643 -
Mm9::chr12:70576497..70576542,-	p1@5830428M24Rik
Mm9::chr13:24743303..24743307,+	p@chr13:24743303..24743307 +
Mm9::chr13:41582464..41582509,+	p@chr13:41582464..41582509 +
Mm9::chr13:41582510..41582539,+	p@chr13:41582510..41582539 +
Mm9::chr13:41582675..41582715,-	p2@Nedd9
Mm9::chr13:67461490..67461531,-	p1@Zfp595 p1@Zfp953
Mm9::chr14:34007113..34007124,-	p@chr14:34007113..34007124 -
Mm9::chr14:47451659..47451732,-	p1@Gm10101
Mm9::chr14:70575163..70575202,-	p6@Pdlim2
Mm9::chr14:75415821..75415830,+	p3@5031414D18Rik
Mm9::chr15:5058492..5058565,-	p1@Card6
Mm9::chr15:74762724..74762736,+	p@chr15:74762724..74762736 +
Mm9::chr15:91503616..91503699,+	p1@Lrrk2
Mm9::chr15:91503712..91503724,+	p@chr15:91503712..91503724 +
Mm9::chr15:91507447..91507451,+	p@chr15:91507447..91507451 +
Mm9::chr16:94444755..94444766,-	p@chr16:94444755..94444766 -
Mm9::chr17:34492178..34492196,+	p@chr17:34492178..34492196 +
Mm9::chr17:50648881..50648922,+	p1@Plcl2
Mm9::chr17:66426152..66426180,-	p@chr17:66426152..66426180 -
Mm9::chr19:12638953..12638980,+	p@chr19:12638953..12638980 +
Mm9::chr19:26681226..26681299,+	p7@Smarca2
Mm9::chr19:40969182..40969226,+	p1@Zfp518a
Mm9::chr1:165993418..165993435,+	p@chr1:165993418..165993435 +
Mm9::chr1:53840652..53840657,-	p@chr1:53840652..53840657 -
Mm9::chr1:65277347..65277376,+	p@chr1:65277347..65277376 +
Mm9::chr1:87546583..87546595,+	p1@Sp100
Mm9::chr2:112105891..112105917,+	p5@Slc12a6
Mm9::chr2:112105940..112105951,+	p7@Slc12a6
Mm9::chr2:112105966..112106015,+	p2@Slc12a6
Mm9::chr2:13493642..13493646,-	p@chr2:13493642..13493646 -
Mm9::chr2:13496593..13496656,-	p@chr2:13496593..13496656 -
Mm9::chr3:102800046..102800083,+	p2@Sike1
Mm9::chr3:19935269..19935283,-	p2@Hps3
Mm9::chr3:19935285..19935325,-	p1@Hps3
Mm9::chr3:59014803..59014805,-	p1@P2ry13
Mm9::chr4:135429461..135429521,-	p2@Pnrc2
Mm9::chr4:147183911..147183930,-	p1@Gm13157
Mm9::chr5:100999251..100999268,+	p@chr5:100999251..100999268 +
Mm9::chr5:121262515..121262548,-	p1@Oas1c
Mm9::chr5:150921201..150921259,+	p1@Fry
Mm9::chr5:65884113..65884128,-	p3@1110003E01Rik
Mm9::chr6:87446273..87446326,-	p2@Arhgap25
Mm9::chr7:111392979..111393005,+	p2@Trim34a
Mm9::chr7:16633729..16633796,+	p@chr7:16633729..16633796 +
Mm9::chr7:25689149..25689160,-	p@chr7:25689149..25689160 -
Mm9::chr7:29566353..29566399,-	p1@Gm19897
Mm9::chr7:80753823..80753860,+	p@chr7:80753823..80753860 +
Mm9::chr7:82731089..82731106,+	p@chr7:82731089..82731106 +
Mm9::chr7:87948107..87948118,-	p2@Iqgap1
Mm9::chr8:125394469..125394500,+	p1@uc009ntw.1
Mm9::chr8:68910191..68910207,+	p1@March1
Mm9::chr8:74713512..74713563,+	p1@Hsh2d
Mm9::chr9:41950159..41950175,+	p@chr9:41950159..41950175 +
Mm9::chr9:45753246..45753276,-	p8@Sidt2

Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data

---

no results for this coexpression

Relative expression of the co-expression cluster over median <br>Analyst:

---

Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>

---

Cell Type

Ontology term	p-value	n

Uber Anatomy

Ontology term	p-value	n

Disease

Ontology term	p-value	n

TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data

---

Novel motifs

JASPAR motifs

Motifs	-log10(p-value)
{{{tfbs_overrepresentation_jaspar}}}